Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy

Journal of Controlled Release : Official Journal of the Controlled Release Society
Wenquan OuJong Oh Kim

Abstract

Immunosuppression in tumor microenvironments induced by regulatory T (Treg) cells is regarded a critical mechanism of tumor immune escape and poses a major impediment to cancer immunotherapy. In this study, we developed tLyp1 peptide-conjugated hybrid nanoparticles for targeting Treg cells in the tumor microenvironment. The tLyp1 peptide-modified hybrid nanoparticles presented good stability and effective targeting to Treg cells, and they enhanced the effect of imatinib in downregulating Treg cell suppression through inhibition of STAT3 and STAT5 phosphorylation. In addition, an in vivo study revealed high tumor accumulation of the hybrid nanoparticle. Specifically, prolonged survival rate, enhanced tumor inhibition, reduced intratumoral Treg cells, and elevated intratumoral CD8+ T cells against tumor were observed when combined with checkpoint-blockade by using anti-cytotoxic T-lymphocyte antigen-4 antibody. This study provided groundwork for a repertoire of nanoparticle-based drugs for targeting and modulating Treg cell function in the tumor microenvironment and for improving antitumor immunotherapy.

Citations

Oct 15, 2018·Journal of Cellular Physiology·Masoud NajafiKeywan Mortezaee
Dec 7, 2018·Journal of Cellular Physiology·Bagher FarhoodKeywan Mortezaee
Nov 1, 2018·Journal of Cellular Physiology·Masoud NajafiKeywan Mortezaee
Jan 23, 2019·Advanced Healthcare Materials·Eun Sook LeeJae Hyung Park
Apr 1, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alejandro Baeza
Oct 3, 2018·Journal of Cellular Biochemistry·Masoud NajafiKeywan Mortezaee
Sep 12, 2019·Advanced Science·Xiangru FengXuesi Chen
May 8, 2020·Journal of Immunology Research·Manal Ali BuabeidGhulam Murtaza
Oct 3, 2018·Biomaterials Research·Wooram ParkDong Keun Han
Sep 19, 2019·Biomaterials Science·May Tun SaungHai-Quan Mao
Nov 27, 2019·Cancers·Lucia SalvioniDavide Prosperi
Apr 1, 2020·Nanoscale Horizons : the Home for Rapid Reports of Exceptional Significance in Nanoscience and Nanotechnolgy·Ping WangBryan Ronain Smith
Oct 31, 2019·World Journal of Gastrointestinal Oncology·Kendra J RoystonOlufunmilayo I Olopade
Sep 19, 2020·Cells·Ernesto BockampDetlef Schuppan
May 14, 2020·Acta Pharmacologica Sinica·Wei-Min YinMin Luo
Feb 11, 2020·Journal of Drug Targeting·Tongtong QiGuimei Lin
Sep 19, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Bin DuHanchun Yao
Aug 22, 2020·International Journal of Nanomedicine·Kyungeun Kim, Dongwoo Khang
Apr 3, 2019·Advanced Science·Yu MiAndrew Z Wang
Jan 12, 2021·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Michael-Joseph GorbetAshish Ranjan
Jan 14, 2021·Nature Nanotechnology·Ningqiang GongMichael J Mitchell
Dec 12, 2020·Acta Pharmaceutica Sinica. B·Yuefei ZhuZhiqing Pang
Dec 29, 2019·Seminars in Cancer Biology·Maria L GuevaraStefano Persano
Nov 2, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cao Dai PhungJong Oh Kim
Jan 29, 2021·Expert Opinion on Drug Delivery·Yuelin FangGuangxi Zhai
Dec 6, 2020·Nature Reviews. Drug Discovery·Michael J MitchellRobert Langer
Jan 8, 2021·Frontiers in Chemistry·Neelam ThakurParames C Sil
Feb 12, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jaehyun KimYong-Hee Kim
Apr 8, 2020·Seminars in Cancer Biology·Jyoti GuptaMehboob Hoque
Sep 25, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hanh Thuy NguyenJong Oh Kim
Feb 23, 2021·Drug Discovery Today·Alexandros Marios SofiasTwan Lammers
Mar 11, 2021·International Journal of Nanomedicine·Zhongmin LiZhenbo Shu
Mar 24, 2021·Cell Communication and Signaling : CCS·Zhen ZhangXuefei Tian
Apr 1, 2021·Cancer Immunology, Immunotherapy : CII·Kristina WittRebecka Hellsten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Expert Opinion on Biological Therapy
Eyad ElkordDavid E Gilham
Gan to kagaku ryoho. Cancer & chemotherapy
Yutaka Shimazu, Hiroyoshi Nishikawa
The Journal of Immunology : Official Journal of the American Association of Immunologists
Nicolas LarmonierEmmanuel Katsanis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Zhifeng MaHaruki Okamura
© 2022 Meta ULC. All rights reserved